CorMedix Inc. (CRMD) KPIs and segments
Close on Nov 16, 2026Market cap $375.69MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive CorMedix's business
CorMedix's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2021 | Q4 2020 | Q4 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product sales, net($M) | 94.3 | 122 | 124 | 102 | 39.7 | 39.1 | 31.2 | 11.5 | |||||
Defen Cath($M) | 66.1 | 97.5 | 91.2 | 88.8 | 39.7 | 39.1 | 31.2 | 11.5 | |||||
Melinta Portfolio($M) | 28.2 | 24.4 | 32.7 | 12.8 | 0 | 0 | |||||||
Contract revenue($M) | 4.97 | 5.51 | 4.64 | 2.73 | 0 | 0 | |||||||
Grant income($M) | 2.62 | 0 | |||||||||||
2 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?